GNC (NYSE:GNC) released its quarterly earnings data on Tuesday. The specialty retailer reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.52) by $0.45, MarketWatch Earnings reports. The firm had revenue of $470.35 million during the quarter, compared to the consensus estimate of $465.40 million. GNC had a negative net margin of 1.70% and a negative return on equity of 22.28%.
Shares of NYSE GNC opened at $0.39 on Thursday. GNC has a fifty-two week low of $0.38 and a fifty-two week high of $3.42. The firm’s 50-day simple moving average is $1.58 and its 200 day simple moving average is $2.31. The stock has a market cap of $39.31 million, a P/E ratio of -0.58 and a beta of 1.34.
A number of equities research analysts have issued reports on the company. ValuEngine cut GNC from a “sell” rating to a “strong sell” rating in a research note on Friday, March 13th. Jefferies Financial Group cut GNC from a “hold” rating to an “underperform” rating and cut their target price for the company from $2.50 to $0.50 in a research note on Tuesday, March 17th.
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise.
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.